As of November 7, 2026, 10 holders' latest Schedule 13D or 13G filings report owning 5% or more of Surrozen, Inc. The largest reported stake is The Column Group III GP, LP's, at 21.4%. 29 filings are on record since August 13, 2025 (Schedule 13D/A, November 6, 2026).
Sell to companies like Surrozen, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Holder: The Column Group III GP, LP · Percent: 21.4% · Shares: 2,951,433 · SCHEDULE 13D/A
- · Holder: The Column Group III GP, LP · Percent: 21.5% · SCHEDULE 13D/A
- · Reporting person: Boxer Capital Management, LLC · Sole voting: 0 · Shared voting: 1,360,683 · Sole dispositive: 0 · Shared dispositive: 1,360,683 · SCHEDULE 13G/A, 2026-10-07
- · Reporting person: Commodore Capital LP · Sole voting: 0 · Shared voting: 885,000 · Sole dispositive: 0 · Shared dispositive: 885,000 · SCHEDULE 13G, 2026-10-01
- · Holder: Braidwell LP · Percent: 3.9% · SCHEDULE 13G/A
Surrozen, Inc. has 29 Schedule 13D or 13G filings on record since 2025-08-13. 10 holders' latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| The Column Group III GP, LP | 21.4% | 2,951,433 | SCHEDULE 13D/A, 2026-11-06 | 2026-11-06 |
| Boxer Capital Management, LLC | 11.6% | 1,360,683 | SCHEDULE 13G/A, 2026-10-07 | 2026-09-30 |
| 9.9% | 1,148,101 | SCHEDULE 13G/A, 2026-07-24 | 2026-07-22 | |
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | 1,205,000 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| RA Capital Management, L.P. | 9.2% | 871,731 | SCHEDULE 13G/A, 2026-02-17 | 2025-12-31 |
| Millennium Management LLC | 8.5% | 726,193 | SCHEDULE 13G/A, 2026-02-05 | 2025-12-31 |
| 5AM Partners VII, LLC | 7.8% | 968,750 | SCHEDULE 13G/A, 2026-08-11 | 2026-06-30 |
| Commodore Capital LP | 7.5% | 885,000 | SCHEDULE 13G, 2026-10-01 | 2026-09-24 |
| Point72 Asset Management, L.P. | 5.4% | 615,957 | SCHEDULE 13G, 2026-04-23 | 2026-04-22 |
| StemPoint Capital LP | 5% | 602,798 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| Braidwell LP | 3.9% | 460,753 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| Stonepine Capital Management, LLC | 3.6% | 316,289 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Nantahala Capital Management, LLC | 2.14% | 225,772 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Driehaus Capital Management LLC | 0.79% | 67,566 | SCHEDULE 13G/A, 2025-08-14 | 2025-06-30 |
Holding shares or following this stake? See who's behind Surrozen, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Surrozen, Inc. and the records around it.
Surrozen, Inc. elsewhere on the record
- Form D filing Apr 2025
- Who owns it
Companies that share a holder
- 5AM Partners VII, LLC also filed stake reports on 1 other company: SKYE BIOSCIENCE, INC. (Sep 2026)
- Boxer Capital Management, LLC also filed stake reports on 1 other company: Q32 Bio Inc. (Nov 2026)
- BRAIDWELL LP also filed stake reports on 1 other company: Amanat Acquisition Corp. (Aug 2026)
Watch Surrozen, Inc.
Get an email when Surrozen, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Surrozen, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Surrozen, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Surrozen, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
30 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| The Column Group III GP, LP | 0 | 2,951,433 | 0 | 2,951,433 | SCHEDULE 13D/A, 2026-11-06 |
| The Column Group III, LP | 0 | 1,386,122 | 0 | 1,386,122 | SCHEDULE 13D/A, 2026-11-06 |
| The Column Group III-A, LP | 0 | 1,565,311 | 0 | 1,565,311 | SCHEDULE 13D/A, 2026-11-06 |
| The Column Group Opportunity III, LP | 0 | 862,068 | 0 | 862,068 | SCHEDULE 13D/A, 2026-11-06 |
| The Column Group Opportunity III GP, LP | 0 | 862,068 | 0 | 862,068 | SCHEDULE 13D/A, 2026-11-06 |
| TCG Opportunity III GP, LLC | 0 | 862,068 | 0 | 862,068 | SCHEDULE 13D/A, 2026-11-06 |
| Tim Kutzkey | 0 | 3,813,501 | 0 | 3,813,501 | SCHEDULE 13D/A, 2026-11-06 |
| Peter Svennilson | 0 | 3,813,501 | 0 | 3,813,501 | SCHEDULE 13D/A, 2026-11-06 |
| Boxer Capital Management, LLC | 0 | 1,360,683 | 0 | 1,360,683 | SCHEDULE 13G/A, 2026-10-07 |
| Boxer Holdings, LP | 0 | 1,360,683 | 0 | 1,360,683 | SCHEDULE 13G/A, 2026-10-07 |
| Boxer Holdings GP, LLC | 0 | 1,360,683 | 0 | 1,360,683 | SCHEDULE 13G/A, 2026-10-07 |
| Aaron Davis | 0 | 1,360,683 | 0 | 1,360,683 | SCHEDULE 13G/A, 2026-10-07 |
| TCG Crossover GP II, LLC | 0 | 574,054 | 0 | 574,054 | SCHEDULE 13G/A, 2026-07-24 |
| TCG Crossover Fund II, L.P. | 0 | 574,054 | 0 | 574,054 | SCHEDULE 13G/A, 2026-07-24 |
| TCG Crossover GP III, LLC | 0 | 574,047 | 0 | 574,047 | SCHEDULE 13G/A, 2026-07-24 |
| TCG Crossover Fund III, L.P. | 0 | 574,047 | 0 | 574,047 | SCHEDULE 13G/A, 2026-07-24 |
| Chen Yu | 0 | 1,148,101 | 0 | 1,148,101 | SCHEDULE 13G/A, 2026-07-24 |
| 5AM Partners VII, LLC | 0 | 968,750 | 0 | 968,750 | SCHEDULE 13G/A, 2026-08-11 |
| 5AM Ventures VII, L.P. | 0 | 968,750 | 0 | 968,750 | SCHEDULE 13G/A, 2026-08-11 |
| Kush Parmar | 0 | 968,750 | 0 | 968,750 | SCHEDULE 13G/A, 2026-08-11 |
| Andrew J. Schwab | 0 | 968,750 | 0 | 968,750 | SCHEDULE 13G/A, 2026-08-11 |
| Commodore Capital LP | 0 | 885,000 | 0 | 885,000 | SCHEDULE 13G, 2026-10-01 |
| Commodore Capital Master LP | 0 | 885,000 | 0 | 885,000 | SCHEDULE 13G, 2026-10-01 |
| Robert Egen Atkinson | 0 | 885,000 | 0 | 885,000 | SCHEDULE 13G, 2026-10-01 |
The latest filing identifies Surrozen, Inc. by CUSIP 86889P208 and gives its principal executive office as 171 Oyster Point Blvd, Suite 400, South San Francisco, CA 94080 (SCHEDULE 13D/A, 2026-11-06).
What the percentages are based on
Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of securities of the Issuer beneficially owned by such Reporting Person as of September 30, 2026 and is incorporated by reference.Boxer Capital Management, LLC, SCHEDULE 13G/A, 2026-10-07
Row 11 of each Reporting Person's cover page to this Schedule 13G sets forth the percentages of the securities of the Issuer beneficially owned by such Reporting Person as of June 30, 2026 and is incorporated by reference.5AM Partners VII, LLC, SCHEDULE 13G/A, 2026-08-11
As of June 30, 2026, each Reporting Person may be deemed to be the beneficial owner of approximately 3.9% of the shares of common stock outstanding.Braidwell LP, SCHEDULE 13G/A, 2026-08-14
Source of funds (Item 3)
The information set forth in Item 3 of the Original Schedule 13D is incorporated herein by reference.The Column Group III GP, LP, SCHEDULE 13D/A, 2026-11-06
Purpose of Transaction (Item 4)
The Column Group III GP, LP
The information set forth in Item 4 of the Original Schedule 13D is incorporated herein by reference.Item 4 of the SCHEDULE 13D/A filed 2026-11-06
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-13 | Stonepine Capital Management, LLC | 5.8% | SCHEDULE 13G/A |
| 2025-08-14 | Driehaus Capital Management LLC | 0.79% | SCHEDULE 13G/A |
| 2025-08-14 | StemPoint Capital LP | 11.4% | SCHEDULE 13G/A |
| 2025-08-14 | Nantahala Capital Management, LLC | 5.18% | SCHEDULE 13G/A |
| 2025-11-20 | Millennium Management LLC | 6.6% | SCHEDULE 13G |
| 2026-01-22 | The Column Group III GP, LP | 35.1% | SCHEDULE 13D/A |
| 2026-02-02 | Chen Yu | 11.4% | SCHEDULE 13G |
| 2026-02-05 | Millennium Management LLC | 8.5% | SCHEDULE 13G/A |
| 2026-02-13 | Stonepine Capital Management, LLC | 3.6% | SCHEDULE 13G/A |
| 2026-02-17 | Braidwell LP | 5.5% | SCHEDULE 13G |
| 2026-02-17 | StemPoint Capital LP | 7% | SCHEDULE 13G/A |
| 2026-02-17 | RA Capital Management, L.P. | 9.2% | SCHEDULE 13G/A |
| 2026-04-23 | Point72 Asset Management, L.P. | 5.4% | SCHEDULE 13G |
| 2026-05-15 | StemPoint Capital LP | 4.5% | SCHEDULE 13G/A |
| 2026-05-15 | Nantahala Capital Management, LLC | 2.14% | SCHEDULE 13G/A |
| 2026-05-15 | Chen Yu | 12.7% | SCHEDULE 13G/A |
| 2026-05-15 | Boxer Capital Management, LLC | 6.67% | SCHEDULE 13G |
| 2026-05-15 | Venrock Healthcare Capital Partners III, L.P. | 9.9% | SCHEDULE 13G/A |
| 2026-05-15 | 5AM Partners VII, LLC | 9.5% | SCHEDULE 13G/A |
| 2026-05-18 | The Column Group III GP, LP | 29.3% | SCHEDULE 13D/A |
| 2026-07-24 | Chen Yu | 9.9% | SCHEDULE 13G/A |
| 2026-08-11 | 5AM Partners VII, LLC | 7.8% | SCHEDULE 13G/A |
| 2026-08-14 | Braidwell LP | 3.9% | SCHEDULE 13G/A |
| 2026-08-14 | StemPoint Capital LP | 5% | SCHEDULE 13G |
| 2026-08-14 | Boxer Capital Management, LLC | 8.9% | SCHEDULE 13G/A |
| 2026-10-01 | Commodore Capital LP | 7.5% | SCHEDULE 13G |
| 2026-10-07 | Boxer Capital Management, LLC | 11.6% | SCHEDULE 13G/A |
| 2026-10-22 | The Column Group III GP, LP | 21.5% | SCHEDULE 13D/A |
| 2026-11-06 | The Column Group III GP, LP | 21.4% | SCHEDULE 13D/A |
Questions about who owns Surrozen, Inc.
Who owns Surrozen, Inc.?
On this page, 10 holders' latest ownership filings report 5% or more of Surrozen, Inc.: The Column Group III GP, LP (21.4%, Schedule 13D/A, filed 2026-11-06), Boxer Capital Management, LLC (11.6%, Schedule 13G/A, filed 2026-10-07), Chen Yu (9.9%, Schedule 13G/A, filed 2026-07-24), Venrock Healthcare Capital Partners III, L.P. (9.9%, Schedule 13G/A, filed 2026-05-15) and RA Capital Management, L.P. (9.2%, Schedule 13G/A, filed 2026-02-17); 5 more are listed above.
Who are the largest shareholders of Surrozen, Inc.?
By the share each holder's latest filing reports, the largest holders of Surrozen, Inc. on this page are The Column Group III GP, LP (21.4%), Boxer Capital Management, LLC (11.6%) and Chen Yu (9.9%).
When did The Column Group III GP, LP buy into Surrozen, Inc.?
The filings give report dates, not purchase dates. The earliest filing from The Column Group III GP, LP on this page is the Schedule 13D/A, filed 2026-01-22, reporting 35.1%; its latest, Schedule 13D/A filed 2026-11-06, reports 21.4%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 29 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Also on the record for Surrozen, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| April 8, 2025 | Form D, private offering | $76.40M sold | Form D page | Source |
Tools for this story
Each opens in a new tab, filled in for Surrozen, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.
